| Financial Year |
March 31 2023 |
| Monetary Funds |
15,034,566.85 |
| Held-for-trading Financial Assets |
420,000.00 |
| Notes Receivable |
89,652,816.18 |
| Accounts Receivable |
134,381,028.63 |
| Advances to Suppliers |
476,219.68 |
| Other Receivables |
798,112.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
41,243,243.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,163,397.98 |
| Total Current Assets |
285,100,074.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
11,460,247.27 |
| Fixed Assetes |
313,713,293.91 |
| Under-construction Projects |
5,201,879.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,866,284.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,582.64 |
| Other Non-Current Assets |
898,024.00 |
| Sub-Total of Non-Current Assets |
352,045,163.50 |
| Total Assets |
637,145,237.68 |
| Short-Term Loans |
216,672,631.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
85,522,065.58 |
| Accounts Received In Advance |
260,536.50 |
| Employee Compensation Payable |
3,725,964.22 |
| Taxes Payable |
4,531,400.67 |
| Interest Payable |
51,253,552.37 |
| Dividend Payable |
-- |
| Other payables |
180,358,249.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,590,810.77 |
| Other Current Liabilities |
63,570,447.47 |
| Sub-Total of Current Liabilities |
559,394,597.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,559,585.58 |
| Total Liabilities |
561,954,182.92 |
| Paid-In Capital(Or Share Stock) |
200,000,000.00 |
| Capital Surplus |
103,754,700.14 |
| Surplus Reserve |
21,587,082.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-252,755,892.28 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
75,191,054.76 |
| Owner's Equity（Stockholder's Equity） |
75,191,054.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
637,145,237.68 |
